Investigation Overview
August 26, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of InterMune Inc (NASDAQ:ITMN), was announced concerning whether the takeover of InterMune Inc by Roche at $74.00 per share is unfair to NASDAQ:ITMN stockholders. The investigation by a law firm concerns whether certain officers and directors of InterMune Inc breached their ...
You must register (for free) or login to view the entire investigation.